Evidence map›Paper›PMID 41219442›Full record

ArticleScientific reports2025

Enhancing recombinant thaumatin production by Komagataella phaffii through cold atmospheric helium plasma jet.

Nivedita Parsekar, Simen Akkermans, Dmytro Kozak, Jan F M Van Impe

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nivedita ParsekarBioTeC+, Chemical and Biochemical Process Technology and Control, KU Leuven, Gebroeders de Smetstraat 1, Ghent, B-9000, Belgium.
Simen AkkermansBioTeC+, Chemical and Biochemical Process Technology and Control, KU Leuven, Gebroeders de Smetstraat 1, Ghent, B-9000, Belgium.
Dmytro KozakBioTeC+, Chemical and Biochemical Process Technology and Control, KU Leuven, Gebroeders de Smetstraat 1, Ghent, B-9000, Belgium.
Jan F M Van ImpeBioTeC+, Chemical and Biochemical Process Technology and Control, KU Leuven, Gebroeders de Smetstraat 1, Ghent, B-9000, Belgium. jan.vanimpe@kuleuven.be.

Funding

Fonds Wetenschappelijk Onderzoek 1224623N
6 · The paper itself

Abstract

Cold atmospheric plasma is emerging as a non-thermal and non-invasive tool for influencing microbial metabolism by modifying bioreactor conditions. This paper validates the effect of a cold atmospheric helium plasma jet on recombinant thaumatin bioproduction by genetically modified Komagataella phaffii. The yeast produced recombinant thaumatin with methanol serving as the carbon and energy source. The cell-free production medium was treated with a helium plasma jet once for 2, 4, 6, and 8 min before inoculation, while the control bioprocess remained untreated. The same treatments were repeated daily on the cell cultures. The results showed no significant effect of the treatment time (2-8 min) on thaumatin production. However, the application of plasma treatments, regardless of the duration, resulted in significant enhancement of 13.3% in protein production compared to the control. No significant difference was observed between residual methanol concentrations with and without plasma treatments, leading to the conclusion that the yield of thaumatin produced per quantity of methanol consumed increased due to plasma treatments. This study thus confirms the hypothesis that cold atmospheric plasma enhances protein production and highlights the probable role of plasma-generated reactive species in this enhancement.

Indexed as

HeliumPlant ProteinsPlasma GasesRecombinant ProteinsSaccharomycetalesBioreactorsMethanolHeliumMethanolPlant ProteinsPlasma GasesRecombinant Proteinsthaumatin protein, plantAtmospheric cold plasmaBioproductionMethanolPichia pastorisRecombinant proteinThaumatin

Identifiers

PMID41219442
PMCPMC12606195

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.